Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
19.88
+0.14 (0.71%)
At close: Mar 4, 2026, 4:00 PM EST
19.71
-0.17 (-0.86%)
After-hours: Mar 4, 2026, 7:00 PM EST
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
The 4 analysts that cover Pediatrix Medical Group stock have a consensus rating of "Hold" and an average price target of $20, which forecasts a 0.60% increase in the stock price over the next year. The lowest target is $17 and the highest is $22.
Price Target: $20 (+0.60%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Pediatrix Medical Group stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $23 → $22 | Hold | Maintains | $23 → $22 | +10.66% | Feb 24, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $24 → $21 | Hold | Maintains | $24 → $21 | +5.63% | Feb 20, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $17 → $24 | Hold | Maintains | $17 → $24 | +20.72% | Nov 10, 2025 |
| UBS | UBS | Hold Maintains $17 → $23 | Hold | Maintains | $17 → $23 | +15.69% | Nov 5, 2025 |
| Leerink Partners | Leerink Partners | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | -14.49% | Sep 5, 2025 |
Financial Forecast
Revenue This Year
1.99B
from 1.91B
Increased by 3.72%
Revenue Next Year
2.04B
from 1.99B
Increased by 2.62%
EPS This Year
2.30
from 1.94
Increased by 18.62%
EPS Next Year
2.40
from 2.30
Increased by 4.18%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 2.0B | 2.1B | ||
| Avg | 2.0B | 2.0B | ||
| Low | 1.9B | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 6.7% | 7.1% | ||
| Avg | 3.7% | 2.6% | ||
| Low | -2.0% | -4.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 2.48 | 2.70 | ||
| Avg | 2.30 | 2.40 | ||
| Low | 2.12 | 2.08 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 27.7% | 17.3% | ||
| Avg | 18.6% | 4.2% | ||
| Low | 9.1% | -9.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.